Connect with us

Business

We’re not in an ‘AI winter’—but here’s how to survive a cold snap

Published

on


Over the nearly three years since ChatGPT’s launch in November 2022, generative AI has created a frenzy that has radiated like the midday summer sun—hot and unrelenting. 

And for the AI companies rocketing forth like heat-seeking missiles, including OpenAI, Anthropic, Google, Microsoft, Meta, and xAI, the sun is still shining: The research firm Gartner forecasts worldwide AI spending will reach nearly $1.5 trillion in 2025 and surpass $2 trillion in 2026, fueled by integration into smartphones, PCs, and enterprise infrastructure. Elon Musk and other AI leaders continue to insist that artificial general intelligence (AGI)—an AI that can think and learn like a human, across many tasks—is on the horizon.

But on the ground, the temperature is dropping, and it’s starting to feel like sweater weather. Among customers and in financial markets, skepticism is rising as some question whether the massive investment in AI will ever be justified by revenues. Startup funding is under sharper scrutiny for small and midsize firms; enterprise projects are stuck in “pilot purgatory”; corporate buyers are questioning return on investment for AI expenditures; and the rising cost of computing power has become a wall many would-be competitors can’t climb.

We don’t yet know whether this chill will eventually turn into an “AI winter,” the industry term for the stage in past AI hype cycles when enthusiasm waned and investment dried up. As my colleague Jeremy Kahn has noted, AI winters have often followed a familiar arc: promising advances that failed to deliver, leaving those footing the bill disillusioned. Sometimes the trigger was academic research exposing the limits of certain techniques. Sometimes it was the failure of real-world adoption. Most often, it was both.

Investment in AI data centers, like this one in Ohio, is soaring.

Eli Hiller—The Washington Post/Getty Images

“There are certainly a few autumnal signs, a falling leaf carried on the breeze here and there, if past AI winters are any guide,” Kahn recently wrote. Only time will tell whether this is “the prelude to another arctic bomb that will freeze AI investment for a generation, or merely a momentary cold snap before the sun appears again.”

The latter scenario may not be such a bad thing. Rowan Curran, a principal analyst at Forrester Research, told Fortune he sees a necessary reset underway. “Our thermometer was broken before,” he said. “Now we’re finally getting the correct temperature.”

Curran emphasized that enterprise clients are not pulling back from AI. Instead, they are recalibrating in the face of overhyped promises. Agentic AI, for example, has been marketed as if all organizations need to roll out universal AI agents to every employee overnight. “Now companies are saying, ‘We don’t necessarily need a generalized agent for everyone tomorrow,’” he explained. “‘We need to think more carefully about our data structures and the quality of our content, so we can take a more deliberate approach.’”

The high-flying dreams of fully realized AGI by 2027 are clearly being tamped down. But that doesn’t mean the commitment to AI is fading. What Curran sees instead is a gap between leadership expectations and practical outcomes. Too often, he said, executives set mandates disconnected from specific business goals, like, “Every employee must use generative AI twice a day.

“That’s when disappointment creeps in,” he said— not because AI is failing outright, but because the expectations were never tied to realistic applications in the first place.

Bill Briggs, chief technology officer of Deloitte, also acknowledges a vibe shift around AI, but he says we’re not facing a dire moment like the late 1990s in tech. “It’s certainly at an inflection point, but I don’t see this being a repeat of the dotcom bust,” he said. AI is still driving transformation, he explained, and new business models are just getting started. 

Overall, he said, AI is becoming less of a rising star and more of an ambient operator that will quietly influence how organizations think about every process, product, and decision. “AI is poised to evolve much like electricity—invisible in our daily lives but powering everything,” he said. 

Not everyone agrees that the temperature is falling. Steve Hall, partner and president of ISG EMEA and chief AI officer at the global technology research and advisory firm, insisted that an AI winter is a remote possibility.

“This is early spring,” he said. “Gen AI is less than three years old, and agentic AI is only 15 months old. The hype cycle is through the roof, but in many cases the bulbs and flowers are just beginning to appear.”

“It’s certainly at an inflection point, but I don’t see this being a repeat of the dotcom bust.”Bill Briggs, Chief Technology Officer, Deloitte

Hall argued that much of the investment so far has been concentrated in chips and at hyperscalers, the massive tech and cloud-computing companies that have spent the past three years building the infrastructure to support their AI projects. Software-as-a-service providers, meanwhile, used 2024 to “agentify” their applications and add intelligence to business processes. 

What skeptics call evidence of stalled adoption, Hall frames as the natural experimentation phase. “We see these pilots not as failures to scale, but as the necessary testing and validation that happens before committing valuable resources. It’s exactly how companies should respond to such an exciting technology,” he said.

Overall, this AI chill may pass, or it may deepen. Either way, history shows that hype alone never keeps the heat on.


For executives trying to cut through the noise, the question isn’t what season we’re in—it’s how to steer AI investments wisely. Experts point to four strategies to weather the chill:

Anchor AI in a strategy

Rowan Curran of Forrester Research cautions that chasing quick wins—like shaving a few seconds off call-center times or blasting out more sales emails—rarely delivers lasting value. “If those efforts aren’t connected to real efficiency, effectiveness, or transformation goals, they’re likely to end in failure,” he said. The companies seeing success are the ones connecting AI pilots directly to measurable outcomes.

Speak the language of business

Bill Briggs of Deloitte said the leaders who secure funding for new AI capabilities aren’t just talking tech—they’re framing AI as a driver of growth. “Your CEO needs to see you as a business partner who happens to know technology, rather than a tech expert who occasionally talks business,” he told Fortune. That means connecting AI initiatives to outcomes that make executives lean forward in their chairs: new markets, happier customers, streamlined operations, and durable competitive advantage.

Build on the ecosystem

With hyperscalers, chipmakers, and software-as-a-service providers laying the foundation, Steve Hall of ISG EMEA argued that enterprises should plug into the broader AI ecosystem instead of trying to build everything in-house. “This is not something you want to go at alone,” he said.

Balance big ambition with practical ingenuity

“My advice to tech leaders is to lead with curiosity and optimism but keep one hand on the wheel of pragmatism,” said Briggs. “The landscape is shifting fast. The goal isn’t simply AI adoption but building AI into the very architecture of your operations.”

This article appears in the October/November 2025 issue of Fortune with the headline “We’re not in an ‘ai winter’—but here’s how to survive a cold snap”



Source link

Continue Reading

Business

Trump wants more health savings accounts. A catch: they can’t pay insurance premiums

Published

on



With the tax-free money in a health savings account, a person can pay for eyeglasses or medical exams, as well as a $1,700 baby bassinet or a $300 online parenting workshop.

Those same dollars can’t be used, though, to pay for most baby formulas, toothbrushes — or insurance premiums.

President Donald Trump and some Republicans are pitching the accounts as an alternative to expiring enhanced federal subsidies that have lowered insurance premium payments for most Americans with Affordable Care Act coverage. But legal limits on how HSAs can and can’t be used are prompting doubts that expanding their use would benefit the predominantly low-income people who rely on ACA plans.

The Republican proposals come on the heels of a White House-led change to extend HSA eligibility to more ACA enrollees. One group that would almost certainly benefit: a slew of companies selling expensive wellness items that can be purchased with tax-free dollars from the accounts.

There is also deep skepticism, even among conservatives who support the proposals, that the federal government can pull off such a major policy shift in just a few weeks. The enhanced ACA subsidies expire at the end of the year, and Republicans are still debating among themselves whether to simply extend them.

“The plans have been designed. The premiums have been set. Many people have already enrolled and made their selections,” Douglas Holtz-Eakin, the president of the American Action Forum, a conservative think tank, warned senators on Nov. 19. “There’s very little that this Congress can do to change the outlook.”

Cassidy’s Plan

With health savings accounts, people who pay high out-of-pocket costs for health insurance are able to set aside money, without paying taxes, for medical expenses.

For decades, Republicans have promoted these accounts as a way for people to save money for major or emergent medical expenses without spending more federal tax dollars on health care.

The latest GOP proposals would build on a change included in Republicans’ One Big Beautiful Bill Act, which makes millions more ACA enrollees eligible for health savings accounts. Starting Jan. 1, those enrolled in Obamacare’s cheapest coverage may open and contribute to HSAs.

Now Republicans are making the case that, in lieu of the pandemic-era enhanced ACA subsidies, patients would be better off being given money to cover some health costs — specifically through deposits to HSAs.

The White House has yet to release a formal proposal, though early reports suggested it could include HSA contributions as well as temporary, more restrictive premium subsidies.

Sen. Bill Cassidy — a Louisiana Republican who chairs the Senate Health, Education, Labor, and Pensions Committee and is facing a potentially tough reelection fight next year — has proposed loading HSAs with federal dollars sent directly to some ACA enrollees.

“The American people want something to pass, so let’s find something to pass,” Cassidy said on Dec. 3, pitching his plan for HSAs again. “Let’s give power to the patient, not profit to the insurance company.”

He has promised a deal can be struck in time for 2026 coverage.

Democrats, whose support Republicans will likely need to pass any health care measure, have widely panned the GOP’s ideas. They are calling instead for an extension of the enhanced subsidies to control premium costs for most of the nearly 24 million Americans enrolled in the ACA marketplace, a larger pool than the 7.3 million people the Trump administration estimates soon will be eligible for HSAs.

HSAs “can be a useful tool for very wealthy people,” said Sen. Ron Wyden of Oregon, the top Democrat on the Senate Finance Committee. “But I don’t see it as a comprehensive health insurance opportunity.”

Who Can Use HSAs?

The IRS sets restrictions on the use of HSAs, which are typically managed by banks or health insurance companies. For starters, on the ACA marketplace, they are available only to those with the highest-deductible health insurance plans — the bronze and catastrophic plans.

There are limits on how much can be deposited into an account each year. In 2026 it will be $4,400 for a single person and $8,750 for a family.

Flexible spending accounts, or FSAs — which are typically offered through employer coverage — work similarly but have lower savings limits and cannot be rolled over from year to year.

The law that established HSAs prohibits the accounts from being used to pay insurance premiums, meaning that without an overhaul, the GOP’s proposals are unlikely to alleviate the problem at hand: skyrocketing premium payments. Obamacare enrollees who receive subsidies are projected to pay 114% more out-of-pocket for their premiums next year on average, absent congressional action.

Even with the promise of the government depositing cash into an HSA, people may still opt to go without coverage next year once they see those premium costs, said Tom Buchmueller, an economics professor at the University of Michigan who worked in the Biden administration.

“For people who stay in the marketplace, they’re going to be paying a lot more money every month,” he said. “It doesn’t help them pay that monthly premium.”

Others, Buchmueller noted, might be pushed into skimpier insurance coverage. Obamacare bronze plans come with the highest out-of-pocket costs.

An HHS Official’s Interest

Health savings accounts can be used to pay for many routine medical supplies and services, such as medical and dental exams, as well as emergency room visits. In recent years, the government has expanded the list of applicable purchases to include over-the-counter products such as Tylenol and tampons.

Purchases for “general health” are not permissible, such as fees for dance or swim lessons. Food, gym memberships, or supplements are not allowed unless prescribed by a doctor for a medical condition or need.

Americans are investing more into these accounts as their insurance deductibles rise, according to Morningstar. The investment research firm found that assets in HSAs grew from $5 billion 20 years ago to $146 billion last year. President George W. Bush signed the law establishing health savings accounts in 2003, with the White House promising at the time that they would “help more American families get the health care they need at a price they can afford.”

Since then, the accounts have become most common for wealthier, white Americans who are healthy and have employer-sponsored health insurance, according to a report released by the nonpartisan Government Accountability Office in September.

Now, even more money is expected to flow into these accounts, because of the One Big Beautiful Bill Act. Companies are taking notice of the growing market for HSA-approved products, with major retailers such as Amazon, Walmart, and Target developing online storefronts dedicated to devices, medications, and supplies eligible to be purchased with money in the accounts.

Startups have popped up in recent years dedicated to helping people get quick approval from medical providers for various — and sometimes expensive — items, memberships, or fitness or health services.

Truemed — a company co-founded in 2022 by Calley Means, a close ally of Health and Human Services Secretary Robert F. Kennedy Jr. — has emerged as one of the biggest players in this niche space.

A $9,000 red cedar ice bath and a $2,000 hemlock sauna, for example, are available for purchase with HSA funds through Truemed. So, too, is the $1,700 bassinet, designed to automatically respond to the cries of a newborn by gently rocking the baby back to sleep.

Truemed’s executives say its most popular products are its smaller-dollar fitness offerings, which include kettlebells, supplements, treadmills, and gym memberships.

“What we’ve seen at Truemed is that, when given the choice, Americans choose to invest their health care dollars in these kinds of proven lifestyle interventions,” Truemed CEO Justin Mares told KFF Health News.

Means joined the Department of Health and Human Services in November after a stint earlier this year at the White House, where he worked when Trump signed the One Big Beautiful Bill Act into law in July. Truemed’s general counsel, Joe Vladeck, said Means left the company in August.

Asked about Means’ potential to benefit from the law’s expansion of HSAs, HHS spokeswoman Emily Hilliard said in a statement that “Calley Means will not personally benefit financially from this proposal as he will be divesting from his company since he has been hired at HHS as a senior advisor supporting food and nutrition policy.”

Truemed is privately held, not publicly traded, and details of how Means will go about divesting have not been disclosed.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.



Source link

Continue Reading

Business

Netflix lines up $59 billion of debt for Warner Bros. deal

Published

on



Netflix Inc. has lined up $59 billion of financing from Wall Street banks to help support its planned acquisition of Warner Bros. Discovery Inc., which would make it one of the largest ever loans of its kind.

Wells Fargo & Co., BNP Paribas SA and HSBC Plc are providing the unsecured bridge loan, according to a statement Friday, a type of financing that is typically replaced with more permanent debt such as corporate bonds.

Under the deal announced Friday, Warner Bros. shareholders will receive $27.75 a share in cash and stock in Netflix. The total equity value of the deal is $72 billion, while the enterprise value of the deal is about $82.7 billion.

Bridge loans are a crucial step for banks in building relationships with companies to win higher-paying mandates down the road. 

A loan of $59 billion would rank among the biggest of its type, Anheuser-Busch InBev SA obtained $75 billion of loans to back its acquisition of SABMiller Plc in 2015, the largest ever bridge financing, according to data compiled by Bloomberg.



Source link

Continue Reading

Business

Stocks: Facing a vast wave of incoming liquidity, the S&P 500 prepares to surf to a new record high

Published

on



The S&P 500 index ticked up 0.3% yesterday, its eighth straight upward trading session. It is now less than half a percentage point away from its record high, and futures were pointing marginally up again this morning. Nasdaq 100 futures were even more optimistic, up 0.39% before the open in New York. The VIX “fear” index (which measures volatility) has sunk 12.6% this month, indicating that investors seem to have settled in for a calm, quiet, risk-on holiday season.

They have reason to be happy. Washington is preparing a wave of incoming liquidity that is likely to generate fresh demand for equities.

For instance, the CME FedWatch index shows an 87% chance that the U.S. Federal Reserve will deliver an interest rate cut next week, delivering a new round of cheaper money. Further cuts are expected in 2026.

Furthermore, Wall Street largely expects President Trump to announce that Kevin Hassett will replace Fed chairman Jerome Powell in May—and Hassett is widely regarded as a dove who will lean in favor of further rate cuts.

Elsewhere, the Fed has begun a series of “reserve management purchases,” a program in which the central bank will buy short-term T-bills—a move that will add more liquidity to markets generally.

Banks, brokers and trading platforms are also lining up to handle ‘Trump Accounts,’ into which the U.S. government will deposit $1,000 for every child. The trust fund can be invested in low-cost stock index trackers—a new source of investment demand coming online in the back half of 2026.

So it’s no surprise that nine major investment banks polled by the Financial Times expect stocks to rise in 2026; the average of their estimates is by 10%.

The Congressional Budget Office also estimates that the One Big Beautiful Bill Act will add 0.9% to U.S. GDP next year largely because it allows companies to immediately deduct capital expenditures from their taxes—spurring a huge round of corporate spending. 

With all that fresh money on the horizon, it’s clear why markets have shrugged off their worries about AI and Bitcoin. The only shock will be if the S&P fails to hit a new all-time high by the end of the year.

Here’s a snapshot of the markets ahead of the opening bell in New York this morning:

  • S&P 500 futures were up 0.2% this morning. The last session closed up 0.3%. 
  • STOXX Europe 600 was up 0.3% in early trading. 
  • The U.K.’s FTSE 100 was up 0.14% in early trading. 
  • Japan’s Nikkei 225 was up 2.33%. 
  • China’s CSI 300 was up 0.34%. 
  • The South Korea KOSPI was down 0.19%. 
  • India’s NIFTY 50 is up 0.18%. 
  • Bitcoin was flat at $93K.



Source link

Continue Reading

Trending

Copyright © Miami Select.